Similar articles

• Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.

  Geraldine N, Marc A, Carla T, Chantal M, Stefaan B, Welcome W, Frank B. Geraldine N, et al. Diabetes Res Clin Pract. 2012 Aug;97(2):331-6. doi: 10.1016/j.diabres.2012.02.002. Epub 2012 Mar 2. Diabetes Res Clin Pract. 2012. PMID: 22386769
• Metformin and cancer.

  Rizos CV, Elisaf MS. Rizos CV, et al. Eur J Pharmacol. 2013 Apr 5;705(1-3):96-108. doi: 10.1016/j.ejphar.2013.02.038. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23499688 Review.
• Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.

  Baur DM, Klotsche J, Hamnvik OP, Sievers C, Pieper L, Wittchen HU, Stalla GK, Schmid RM, Kales SN, Mantzoros CS. Baur DM, et al. Metabolism. 2011 Oct;60(10):1363-71. doi: 10.1016/j.metabol.2010.09.012. Epub 2010 Nov 16. Metabolism. 2011. PMID: 21081242
• Metformin and the incidence of cancer in patients with diabetes: a nested case-control study.

  Wang SY, Chuang CS, Muo CH, Tu ST, Lin MC, Sung FC, Kao CH. Wang SY, et al. Diabetes Care. 2013 Sep;36(9):e155-6. doi: 10.2337/dc13-0708. Diabetes Care. 2013. PMID: 23970729 Free PMC article. No abstract available.
• [Anti-cancer activity of metformin: new perspectives for an old drug].

  Beck E, Scheen AJ. Beck E, et al. Rev Med Suisse. 2010 Sep 1;6(260):1601-7. Rev Med Suisse. 2010. PMID: 20853715 Review. French.